About Vineeta Agarwala
Vineeta Agarwala is a general partner at Andreessen Horowitz and an adjunct clinical professor at Stanford. She serves on 13 company and industry boards, including BigHat Biosciences.
She previously invested at GV and worked at Flatiron Health and McKinsey. She has also been a data scientist. She also conducted research at the Broad Institute, Lawrence Livermore National Laboratory and Cold Spring Harbor Laboratory.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Vineeta Agarwala in the role, so the role may have started earlier or lasted longer.
BigHat Biosciences, Inc. Current
Director
2021 – Present · San Mateo, CA
BigHat combines AI with an automated laboratory to design antibody drugs and advance its own and partners' programs.
AH
Andreessen Horowitz Current
General partner
SU
Stanford University Current
Adjunct clinical professor
AB
Amber Bio Current
Director
GB
Gate Bio Current
Director
GT
GC Therapeutics Current
Director
OT
Orbital Therapeutics Current
Director
PH
Pearl Health Current
Director
PC
Pomelo Care Current
Director
TH
Tenet Healthcare Current
Director
NA
National Venture Capital Association Current
Board chair
Stipple Bio, Inc.
Director
2022 – 2026 · Cambridge, MA
Develops targeted cancer medicines for people with cancer.
GV
GV
Venture investor
FH
Flatiron Health
Director of product management
MC
McKinsey & Company
Management consultant
BI
Broad Institute
Researcher
LL
Lawrence Livermore National Laboratory
Researcher
CL
Cold Spring Harbor Laboratory
Researcher
Key Colleagues at Startups
The people Vineeta Agarwala works with at each company, as listed on that company's latest Form D.
BigHat Biosciences, Inc. · Form D, Oct 26, 2026
Peyton Greenside
Chief Executive Officer and Co-founder, director
Robert Chess
Chairman
Francisco Gimenez
Director
Andrew Conrad
Director
Stipple Bio, Inc. · Form D, Apr 6, 2026
GV
Greg Verdine
Independent Director
TS
Thilo Schroeder
Managing Partner, Nextech and director
OH
Owen Hughes
Independent Director
AR
Aaron Ring
Associate Professor, Fred Hutch and director
DD
Derek DiRocco
Partner, RA Capital Management and director
Jeffrey Landau
Chief Executive Officer and director
knownwell, inc. · Form D, Oct 21, 2025
BW
Ben Wanamaker
Director
AF
Angela Fitch
Executive officer
BP
Brooke Boyarsky Pratt
Chief Executive Officer and director
Ian Chiang
Director
Thyme Care, Inc. · Form D, Sep 25, 2025
DW
David Whelan
Director
BD
Bradford Diephuis
Executive officer
RG
Robert Green
Executive officer and director
BB
Brian Belsky
Director
MM
Michael Markowicz
Executive officer
VG
Vivek Garipalli
Director
EC
Elizabeth Canis
Director
RS
Robin Shah
Chief Executive Officer and director
VP
Vijay Patel
Director
BF
Brenton Fargnoli
Director
PS
Puneet Singh
Director
JW
Jesse Waldron
Executive officer
Rezo Therapeutics, Inc. · Form D/A, Aug 18, 2025
SG
Simeon George
Director
DH
Derek Hicks
Executive officer and director
NK
Nevan Krogan
Executive officer and director
TA
Tiba Aynechi
Director
JC
Jennifer Chang
Secretary
GS
George Scangos
Director
NB
Norbert Bischofberger
Director
Arda Therapeutics, Inc. · Form D, Oct 2, 2024
AF
Adam Freund
Chief Executive Officer and director
Waymark, Inc. / DE · Form D, Nov 30, 2023
SB
Sanjay Basu
Executive officer and director
MM
Mohamad Makhzoumi
Director
RB
Rajaie Batniji
Chief Executive Officer and director
Vineeta Agarwala in the News
Sources
- SECBigHat Biosciences, Inc. Form D, filed Oct 26, 2026
- SECStipple Bio, Inc. Form D, filed Apr 6, 2026
- SECknownwell, inc. Form D, filed Oct 21, 2025
- SECThyme Care, Inc. Form D, filed Sep 25, 2025
- SECRezo Therapeutics, Inc. Form D/A, filed Aug 18, 2025
- SECArda Therapeutics, Inc. Form D, filed Oct 2, 2024
- SECWaymark, Inc. / DE Form D, filed Nov 30, 2023
- CompanyBigHat biography of Vineeta Agarwala
- InvestorAndreessen Horowitz investment article for Arda Therapeutics
- InvestorAndreessen Horowitz investment article for Stipple Bio